cellular MDS (refractory anemia with excess of blasts: RAEB) Keywords: cell lines; AML-M5a; interclonal phenotypic heteroafter which trilineage hematopoietic recovery was attained geneity; insertion; MLL-AF9 without detectable blast infiltration. At diagnosis of MDS, interface cytogenetic and RT-PCR analyses, respectively, showed trisomy 8 and absence of AF9-MLL rearrangement in Introduction the bone marrow (BM). On readmission with florid leukemia, his peripheral white blood cell count was 13 200/mm 3 , with A subtle, reciprocal translocation exchanging the terminal 56% leukemic blasts. His hemoglobin concentration was short and long arm segments of chromosomes 9 and 11, 15.0 g/dl, and his platelet count was 22 000/mm 3 . The bone respectively t(9;11)(p21-22;q23), is associated with acute marrow aspiration showed 92% leukemic blasts, and the mormyeloid leukemia (AML)-M5, 1 particularly the M5a subtype.
without detectable blast infiltration. At diagnosis of MDS, interface cytogenetic and RT-PCR analyses, respectively, showed trisomy 8 and absence of AF9-MLL rearrangement in Introduction the bone marrow (BM). On readmission with florid leukemia, his peripheral white blood cell count was 13 200/mm 3 , with A subtle, reciprocal translocation exchanging the terminal 56% leukemic blasts. His hemoglobin concentration was short and long arm segments of chromosomes 9 and 11, 15.0 g/dl, and his platelet count was 22 000/mm 3 . The bone respectively t(9;11)(p21-22;q23), is associated with acute marrow aspiration showed 92% leukemic blasts, and the mormyeloid leukemia (AML)-M5, 1 particularly the M5a subtype. 2 phological diagnosis was made as AML-M5a. Cytogenetic Ascertainment may be difficult in suboptimal preparations analysis was interpreted as: 47, XY, +8, t(9;11)(p22;q23). and, despite being regarded as the 'standard' cytogenetic Immunophenotyping analysis of fresh leukemia blasts change in acute monoblastic leukemia, its overall incidence revealed no significant expression of CD antigens associated and pattern of associations remain uncertain. 2 A recent study with the myelo-monocytic lineage. CD34 was 30% positive comparing AML-M1 and -M5 patients, analyzed simuland non-lineage-associated HLA-DR was found to be positive taneously by reverse transcriptase-polymerase chain reaction at 70%; whereas those indicative of lymphoid lineage includ-(RT-PCR), Southern blotting and fluorescence in situ hybridizing CD3, CD4, CD8, CD10, CD19 were absent or weakly ation (FISH) with an MLL-specific yeast artificial chromosome expressed. Myeloperoxidase activity was weakly detected on (YAC) probe, suggests the overall incidence of MLL rearrangethe fresh leukemic blasts. Despite receiving chemotherapy, he ment in AML-M5 may be as high as 60%. 3 It was apparent in succumbed to rapidly progressive leukemia on 15 August that study that approximately half the cases with MLL 1995. rearrangement went undetected by cytogenetic methods, including a cryptic t(6;11)(q27;q23) resulting from a cytogenetically invisible insertion juxtaposing AF6 and MLL.
Materials and methods A case of AML-M5a with de novo MLL-AF9 fusion evolving from MDS with trisomy 8 present at all phases has recently Hypaque density centrifugation. The interface containing anti-human immunoglobulins (Igs) specific for and light chains and for ␣, ␦, ␥ and heavy chains (Cappel Laboramononuclear cells was harvested and washed twice with fresh RPMI 1640 (Nissui Pharmaceutical, Tokyo, Japan) culture tories, West Chester, PA, USA), rabbit anti-terminal deoxynucleotidyl transferase (TdT) (P-L Biochemicals, Milwaukee, WI, medium. Mononuclear cells were suspended in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS: USA), monoclonal antibodies (mAbs) CD3 (NU-T3), CD4 (NU-Th/i), CD8 (NU-Ts/c), CD10 (NU-N1), CD20 (NU-B2), GIBCO, Grand Island, NY, USA) and antibiotics, 100 U/ml penicillin and 50 g/ml streptomycin without any other CD13 (MCS-2), NU-Ia for HLA-class II (Nichirei, Tokyo, Japan), CD19 (B4), CD33 (MY9), CD34 (MY10) (Coulter growth factors, and were incubated in two plastic culture flasks at 37°C in a humidified 5% CO 2 atmosphere. Each culImmunology, Hialeah, FL, USA). All mAbs were used in an indirect immunofluorescence (IF) test with FITC-conjugated ture was then fed once a week by replacing one half to one third of the volume of the culture contents with fresh nutrient goat anti-mouse IgG or IgM (Cappel Laboratories). In addition to the immunophenotyping of the fresh leukemia cells, the medium during the subsequent 2 weeks. In the third week, a slow yet sustained proliferation of cultured cells was noted following mAbs were used to type the established cell lines: CD11a (SPV-L7; purchased from Nichirei); CD9 (BA-2; gift in both flasks which were then designated as MOLM-13 and MOLM-14.
from Dr TW LeBien, University of Minnesota, Minneapolis, MN, USA); CD14 (MY4; purchased from Coulter The cell lines were found to be free of mycoplasma infection using standard broth-agar cultivation and DAPI staining. The cells were cultured in RPMI 1640 with several stimuli. Prior to starting the experiments, the cultured cells were hareled with FITC covering chromosomes 8, 11, 14 and 19 (Cambio, Cambridge, UK) and chromosome 9 directly labeled vested and washed twice with RPMI 1640 medium, and resuspended in fresh medium; then the cell count was adjusted to with Spectrum Orange (Gibco-BRL, Paisley, UK). Hybridization and detection followed manufacturer's protocols except 5 × 10 5 cells/ml. INF-␥ (1000 IU/ml), TNF-␣ (3 Japanese reference units; JRU/ml) (Hayashibara Biochemical Labs, Okaythat the stringency of the post-hybridization washes after hybridizing with chromosome painting probes was reduced ama, Japan), macrophage colony-stimulating factor (M-CSF) (50 U/ml), granulocyte-macrophage colony-stimulating factor by washing in 1 × SSC, intended to intensify signal strength, albeit at the expense of 'background noise'. Slides were coun-(GM-CSF) (20 ng/ml) (Genzyme, Cambridge, MA, USA) were added to the culture at the appropriate conditions. The cells terstained with 4,6-diamidino-2-phenylindole (DAPI) (Sigma) and mounted in a commercial antifade solution (Vectashield;
were incubated at 37°C in an humidified 5% CO 2 atmosphere for 3 days. After incubation, differentiation was judged by Camon, Wiesbaden, Germany) and examined microscopically by epifluorescence. Photographic images of fluorescellular morphology and CD antigen expression. Briefly, the stimulated cells were harvested after the incubation period, cently illuminated chromosome preparations were recorded on Kodak Ektachrome 400 daylight reversal film.
and washed twice with PBS (phosphate-buffered saline). The Fc receptors on the cell surfaces were blocked with 1 mg/ml ␥-globulin (Sigma, St Louis, MO, USA) for 15 min at room
Reverse Transcriptase-Polymerase Chain Reaction (RTtemperature, then the cells were washed once with PBS. Using PCR) the mAbs listed in Table 2 , an indirect IF test was performed by the method described in the immunophenotyping section. Total RNA was isolated from cell pellets using standard guanidinium thiocyanate and ultracentrifugation methods. Five
Immunofluorescent-positive cells were determined by flow cytometry (EPICS-Profile; Coulter Electronics, Hialeah, FL, micrograms of the total RNA were used for the synthesis of first strand cDNA applying a reverse transcriptase preamplifi-USA). cation kit (SuperScript; Gibco BRL, Eggenstein, Germany). Peripheral blood mononuclear cells obtained from the patient were cultured as described in Materials and methods. The to the reaction and incubated at 42°C for 50 min. The reaction was stopped by heating to 90°C for 5 min and then quickly cells were maintained without any feeder cells or growth factors. The first subculture was made from each flask at 4 weeks chilled on ice. After brief centrifugation, 2 U of RNase H were added to the reaction mixture and incubated for 20 min at after the cultures were started. The cells proliferated consistently as free-floating single cells in suspension. When estab-37°C. Two microliters of the first strand cDNA (corresponding to 0.5 g of RNA) were diluted with PCR buffer (10 × 500 mM lished, the cell lines were designated MOLM-13 and MOLM-14, respectively. Both cell lines have since been maintained KCl, 15 mM MgCl 2 , 100 mM Tris-HCl pH 8.8, 0.8% Nonidet P40) containing 20 pmol of each upstream and downstream in RPMI 1640 supplemented with 10% FCS, and each has a primer, 10 nmol of dNTP mix and 1.25 U of Taq DNA polymerase (MBI Fermentas, St Leon-Rot, Germany) for the PCR Table 2 Modulation of CD antigens by cytokines reaction. To detect the MLL-AF9 fusion product the primers used were sense F-MLL (5′-CTGAATCCAAACAGGCCAC- observed under UV-light.
New AML-M5a cell lines with ins(11;9)(q23;p22p23) Y Matsuo et al 1472 The following markers were additionally tested (data not shown). T/NK cell marker: CD1, CD2, CD3, CD5, CD7, CD8, CD57; B cell markers, CD10, CD19, CD20, CD21, CD22, CD23, CD40; erythroid-megakaryocytic markers: CD41a, CD42b, CD61, CD62p.
doubling time of 3-4 days. Both cell lines were grown conThe cells had round or lobulated nuclei with fine chromatin and prominent nucleoli and slightly basophilic cytoplasm tinuously for 18 months. Maximum cell density is at 2.6 × 10 6 cell/ml. Optimal split ratio is 1:1 at 0.5 × 10 6 cell/ml with fresh ( Figure 1a and b) . MOLM-13 cells were negative, whereas about 5% of MOLM-14 cells were positive for POX staining medium for every 2-3 days. The cells can be cryopreserved in defined medium (80% medium, 10% FCS, 10% DMSO), (Figure 2 ). stored in liquid nitrogen, thawed again (with viabilities of more than 70%) and successfully reconstituted. The data presented here were obtained from cells that had been in Immunophenotypic marker profiles culture for 14 months since establishment.
The immunophenotypic marker profiles of the two cell lines and the patient's original leukemia cells are summarized in Expression of monocyte-specific esterase isoenzyme Both MOLM-13 and MOLM-14 strongly express a band in the isoelectric focusing analysis that is specific for monocytes ( Figure 3 ).
Chromosome analysis
The consensus GTG karyotypes of subclones present MOLM-13 (that of the stemline is shown in Figure 4a) (2)t(1;2)(q11;q31) [4] /idem 50, +14, −del(14), +19 [3] . The frequency of near-tetraploid cells also approximated 4%. The 14q− present in both major subclones of MOLM-14 differed from that in MOLM-13; the proximal breakpoint in the former being closer to the centromere (14q13.2) vs (14q23.3); while the distal breakpoints chromosome pairs 9 and 11 ( Figure 4b ) indicated the deletion strongly expressed. CD115 for the M-CSF receptor was not detectable for MOLM-13 and was only 10% for MOLM-14. However, differences in antigen expression which are highly associated with myelomonocytic lineages were noted between the two cell lines: MOLM-13 was positive for CD4, CD11a, CD15, CD32, CD33, CD87, CD92, CD93, CD116 and CD119, whereas MOLM-14 was positive for CD4, CD9, CD11a, CD13, CD14, CD15, CD32, CD33, CD64, CD65,
Figure 3
Proteins extracted from various cell lines were separated by isoelectric focusing on a polyacrylamide gel and stained with an esterase staining. The monocyte-specific esterase (MSE) band is indicated by an arrow. Note that both MOLM-13 and MOLM-14 strongly express the MSE band, whereas six other cell lines do not display this enzyme marker. Derivation of cell lines: OCI-AML-10 from AML-M2; OCI-AML-11 from AML-M2; UT-7 from AML-M7; and SAM-1 from Figure 2 Myeloperoxidase staining of MOLM-14 cells. Arrows indicate positive cells (original magnification × 312).
CML in myeloid blast crisis.
Figure 4
Karyotype of MOLM-13.
(a) Depicts cell of the predominant clone (stemline): 49,Ͻ2nϾ,XY,+6,+8,ins (11;9)(q23.3;p21.3p22/p22p23.2), +13, del(14)(q23.3q31.3). The karyotype of MOLM-14 was identical excepting a more extensive 14q− which was del(14)(q13.2q31.3). Trisomies for chromosomes 6, 8, 13 and 19 (the last present in sublines of both sister cell lines) are the four commonest numerical aberrations secondary to t(9;11). (b) Partial karyotype shows normal and rearranged chromosomes 9 and 11. Lightly staining (Gnegative) material comprising band p22 deleted from der (9) has been inserted at band q23 in the der(11). This rearrangement was not apparent in suboptimal preparations.
of lightly-staining (G-negative) material comprising band Hybridization with the MLL genomic probe revealed two signals of equal intensity contraindicating rearrangement or 9p22, possibly together with a little adjacent G-positive material (ie, 9p21.3 or 9p23.1), and its insertion at 11q23. 3. deletion of this locus on 11q (Figure 5b) . No signals were detectable on the short arm region of the der(9). Thus MOLMAlthough the der(9) was quite apparent in most cells, in suboptimal preparations the der(11) bearing the insertion was 13 exhibited a hybridization pattern with MLL indistinguishable from that of normal cells, whereas t(9;11) is normally usually indistinguishable from its normal homologue.
Simultaneous hybridization of contrastingly labeled paintaccompanied by a split signal when hybridized with this probe. ing probes for chromosomes 9 and 11 (Figure 5a ) confirmed the insertion of a small amount of chromosome 9 material in Together, the cytogenetic findings indicated that MOLM-13 and MOLM-14 both comprised a number of closely related distal 11q without the reciprocal transfer of chromosome 11 material, unlike controls positive for typical t(9;11)(p22;q23), clones, with the putative progenitor karyotype, 49,Ͻ2nϾ,XY,+6,+8, ins(11;9)(q23;p22p23), +13. eg, Mono Mac 6 (data not shown).
whereas the normal AF9 mRNA shows only weak expression in the RT-PCR assay ( Figure 6 ). The expression pattern is similar to that of the Mono Mac 6 cell line which expresses the (9;11) fusion transcript but not the normal AF9 mRNA.
Response to cytokines
When the MOLM-13 cells were cultured with IFN-␥, or IFN-␥ and TNF-␣, differentiation to macrophage-like cells was induced as judged by cellular morphology (Figure 7a ) and by the induction and upregulation of CD antigen expression (Table 2) . IFN-␥ upregulated myelomonocyte-associated CD antigen expression of CD13, CD14 and CD64, and the combination of IFN-␥ and TNF-␣ further enhanced this effect. However, M-CSF (50 U/ml) and GM-CSF (20 ng/ml) did not produce any changes in the expression of those antigens. The cellular morphology did not change upon stimulation with M-CSF or GM-CSF. Changes in the expression of CD antigens by IFN-␥ or the combination of IFN-␥ and TNF-␣ on MOLM-14 were also determined. The myelomonocyte-associated CD antigens tested, including CD13, CD14, CD15, CD64, CD65 and CD87, were all upregulated. However, with M-CSF and GM-CSF, as shown in MOLM-13, no significant changes were seen. The cellular differentiation of MOLM-14 stimulated with IFN-␥ or the combination of IFN-␥ and TNF-␣ showed a more pronounced differentiation towards macrophage-like cells than that of MOLM-13, as judged by cellular morphology. In particular, MOLM-14 cells stimulated with the combination of IFN-␥ and TNF-␣ were larger in diameter, and had irregularly shaped nuclei with a rough chromatin network and vacuolated cytoplasm. Degenerated small round cells presenting as apoptotic bodies were also seen (Figure 7b ).
Figure 5
FISH analysis of ins(11;9) in MOLM-13. (a) Depicts chromosome painting with probes for chromosomes 9 (Spectrum Orange) and 11 (FITC). The arrow indicates insertion of material from chromosome 9 into distal 11q. To intensify signal-strength of insertion, posthybridization washes were performed at reduced stringency resulting in increased background labeling of centromeric DNA. (b) Depicts hybridization with an MLL probe labeled with digoxigenin, detected using an anti-digoxin mAb labeled with FITC. Only two signals were present (arrows) mimicking result obtained with normal cells. Absence of signal-splitting thus distinguishes ins(11;9) from t(9;11), although both rearrangements affect MLL-AF9 fusion. FISH preparations in both (a) and (b) were counterstained with DAPI and viewed through a three-color bandpass filter. The normal MLL mRNA is expressed in normal quantities, like cells accompanied by an upregulation of the intensity and percentage of several myelomonocyte-associated antigens including CD14, CD15, CD64, CD65 and CD87. The expression of receptors for IFN-␥ and TNF-␣, both type A and type B, was analyzed using specific mAbs. The receptor for IFN-␥ was positive in both cell lines, however, receptor type A for TNF-␣ was negative for both cell lines; receptor type B was detected in only 10% of MOLM-14 cells. Differentiation induced by the combination of IFN-␥ and TNF-␣ can be explained by undetectable expression due to the limited number of receptor molecules. The apoptotic bodies which were seen after IFN-␥ and TNF-␣ treatment might be caused by the direct effect of IFN-␥ or TNF-␣. Lee and Esteban 12 showed that transfection and expression of the IFN-induced doublestranded RNA-activated protein kinase, a serine/threonine kinase, in a human tumor cell line resulted in rapid apoptotic cell death. 12, 13 This mechanism could be involved partially in the apoptotic cell death caused by IFN-␥ and TNF-␣ in the present study.
We have shown that both sister cell lines, MOLM-13 and MOLM-14, are closely related karyotypically and are likely to represent mixtures of clones derived from a common progenitor carrying ins(11;9) as well as trisomies for chromosomes 6, 8 and 13. The presence of MLL-AF9 chimeric mRNA together with the common involvement of 9p22/23 and 11q23 breakpoints in the insertion shows that the ins(11;9) rearrangement mimics t(9;11), both structurally and functionally. Interestingly, all trisomies observed in the various subclones of both MOLM-13 and MOLM-14 ie, +6, +8, +13, +19, together with +X, seen in one (MOLM-13) cell, comprise all the commonest numerical abnormalities associated with t(9;11) in AML.
14 The consistency of this association, together with their presence in both sister cell lines, indicates an in vivo origin for all numeri-
Figure 7
Wright-Giemsa-stained preparation of (a) MOLM-13 cal changes. The MLL gene has been found to be involved in several of IFN-␥ (1000 IU/ml) and TNF-␣ (3 JRU/ml) (original magnification translocations affecting 11q23 including t(4;11), t(6;11), + , CD14 + , CD15 + , CD33 + , were established ences in the present case imply significant under-ascertainment of MLL rearrangement via small deletions of which only from the peripheral blood of a patient with AML-M5a. In addition to the above antigens, expression of others including two instances have been described. 3, 19 However, as the present report documents, improved ascertainment of MLL CD9, CD64, CD65, CD87, CD92 and CD155 was also found to be different between the two cell lines. The differences seen rearrangement due to minute insertions may not be guaranteed by molecular cytogenetic detection. in the immunoprofiles of the two cell lines, however, suggest interclonal phenotypic heterogeneity despite the fact that they
The donor patient is reportedly the first case of MLL-AF9 arising de novo in AML evolving from MDS 4 implying distinct were derived from the same specimen, which is supported by the fact that they share the common cytogenetic abnormality, primary roles for +8 and MLL-AF9 in the respective ontogenies of MDS and AML phases. The presence of both rearranget(11;9)(q23;p22p23). Most cells of both cell lines had a blastic appearance, but a small percentage of the cells showed ments in the cell lines, together with additional trisomies for chromosomes 6, 13, and 19, suggests a direct line of leukemomacrophage-like features with myeloperoxidase positivity.
Both cell lines were found to be positive for MSE, clear-cut genic descent marked by cumulative chromosome change at successive stages from MDS (+8) through onset of acute leukeevidence that they were both of monocytic origin. 7, 8, 10 The cause of this heterogeneity remains unknown, thus the followmia (evolution of MLL-AF9) and onward to relapsing AML (additional trisomies). ing possibilities are proposed: (1) the two cell lines may represent distinct stages of differentiation; or (2) 29 are some of the cell lines described so far. Among these cell lines, THP-1, appear to be promising therapeutic agents against tumor cells.
11 Stimulation of MOLM-13 and MOLM-14 with IFN-␥ Mono Mac 6, and IMS-M1 are known to have the t(9;11) chromosomal abnormality. 6 It is of note that the immunoproand TNF-␣ resulted in cellular differentiation to macrophage-
